Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Greif Announces Retirement of General Counsel Gary Martz
-
SharpLink Announces Total ETH Holdings Increased to 797,704 as of August 24, 2025; Raised $360.9 Million in Net Proceeds for Week of August 18 - August 22, 2025
-
ASP Isotopes Inc. Hosts South African Investors in Advance of Secondary Listing on the Johannesburg Stock Exchange (JSE) and Provides Updates on its Isotope Production Plants
-
Jupiter Neurosciences Launches Nugevia™ Website and Opens Pre-Orders for Groundbreaking Longevity Supplements
-
Bitcoin Depot Taps Fintech Executive Alex Holmes for Board of Directors
-
TRU Staffing Partners Rebrands as TruLegal to Meet the Future of AI-Enabled Legal Work
-
Nuvini Group to Release 1H25 Financial Results on September 30, 2025
-
Ashvattha Therapeutics to Present Late-Breaking Phase 2 DME and nAMD Data at 25th EURETINA Congress
-
Incannex Reports Positive Results from Phase 2 Clinical Trial of PSX-001 (Psi-GAD) for Generalised Anxiety Disorder
-
Fulcrum Therapeutics to Present at Upcoming Investor Meetings
-
Magnite Rolls Out Pause Ads as Streaming Media Owners Embrace Next-Gen Ad Formats
-
WaveMaker Launches TestDrive, A White-label Try-Before-You-Buy App for AT&T MVNx Ecosystem
-
Nine Goranson Bain Ausley Attorneys Named 2026 Best Lawyers: Ones to Watch® in America — Highest Number of Family Law Honorees in Texas
-
Lacerta’s ReCERTA™ Products Achieve Globally Recognized PCR Certification
-
BlueCat Networks unveils channel-first strategy with launch of BlueCatalyst Partner Program
-
Prime Medicine to Participate in Upcoming Investor Conferences
-
Legend Biotech to Participate in the Morgan Stanley Global Healthcare Conference
-
Esperion to Participate in Upcoming September Investor Conferences
-
InnovAge to Announce Fourth Quarter and Fiscal 2025 Financial Results and Host Conference Call Tuesday, September 9, 2025
-
The Mullings Group Companies Announces Official Launch of its Strategic Initiative Service
-
Genmab Receives FDA Breakthrough Therapy Designation for Rinatabart Sesutecan (Rina-S®) in Advanced Endometrial Cancer (EC)
-
Allarity Therapeutics Granted FDA Fast Track Designation for Stenoparib for the Treatment of Advanced Ovarian Cancer
-
21Shares Renames Spot Ethereum Product
-
Proxygen and EPFL Launch Strategic Collaboration to Advance AI-Driven Glue Discovery
-
IBN Announces Latest Episode of The TechMediaWire Podcast featuring Erik Carlson, CEO of Notified
-
IAV Group Joins SDVerse to Accelerate Software Innovation and Drive the Future of Mobility
-
Clearing Organizational Roadblocks That Keep You From Doing Your Job
-
Foresight: Continental and Eye-Net Collaborate to Enhance Road Safety Systems
-
Sofascore Player of the Season Award Show Premieres on CBS
-
Firefly Neuroscience Successfully Deploys NVIDIA L40S GPU Acceleration to Power Next-Gen ‘CLEAR’ Platform
-
BriaCell’s Bria-OTS+™ Mechanism of Action Validated in Highly Rated Peer Reviewed Cancer Journal
-
Purpose Investments Inc. Announces Final August 2025 Distribution Rate for Purpose High Interest Savings Fund, Purpose US Cash Fund, Purpose Cash Management Fund, and Purpose USD Cash Management Fund
-
Altimmune to Participate in Upcoming Investor Conferences
-
Bowman to Attend D.A. Davidson Industrials Conference in September
-
GAMCO Natural Resources, Gold & Income Trust Increases Monthly Distribution 25%
-
Plus Therapeutics Regains Compliance with Applicable Nasdaq Listing Criteria
-
Curanex Pharmaceuticals Inc. Announces Pricing of its Initial Public Offering
-
Zevra Therapeutics to Participate at Upcoming Investor Conferences in September
-
Dynamix Announces New Ticker Symbol “ETHM” to Reflect Planned Business Combination with The Ether Machine
-
Sky Quarry to Host Live Investor Webinar on August 29, 2025
-
Bancroft Fund Ltd. Increases Annual Distribution 10% to $1.40 From $1.28
-
GAMCO Natural Resources, Gold & Income Trust Increases Monthly Distribution 25%
-
Orchestra BioMed Announces Publication of Clinical Data Demonstrating Favorable Blood Pressure and Hemodynamic Effects of AVIM Therapy in JACC: Clinical Electrophysiology
-
Anavex Life Sciences Reports New Publication in Medical Journal Highlighting the Established Precise Autophagy Mechanism with Blarcamesine
-
DraftKings Launches Responsible Gaming Education Month Campaign Featuring Super Bowl Tickets Sweepstakes
-
FuelCell Energy Announces Third Quarter 2025 Results Conference Call on September 9, 2025 at 10:00 A.M. Eastern Time
-
Ellsworth Growth and Income Fund Ltd. Increases Annual Distribution 20% to $0.76 From $0.64
-
EUROCOMMERCIAL PROPERTIES N.V.: INVITATION TO THE HALF YEAR 2025 RESULTS CONFERENCE CALL AND WEBCAST
-
Draganfly Uniquely Positioned to Support Canada’s New $2 Billion Military Commitment to Ukraine with Advanced Drone and Tactical Capabilities
-
The Save Mart Companies Honored for Transforming Workers’ Comp Program in Collaboration with CorVel
